Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Jazz Pharmaceuticals plc - Ordinary Shares
(NQ:
JAZZ
)
164.42
-3.43 (-2.04%)
Streaming Delayed Price
Updated: 11:54 AM EST, Jan 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
218,578
Open
167.34
Bid (Size)
164.40 (200)
Ask (Size)
164.95 (300)
Prev. Close
167.85
Today's Range
164.42 - 168.05
52wk Range
95.49 - 182.99
Shares Outstanding
62,311,104
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed?
↗
January 27, 2026
Some investors haven't gotten answers to their questions about the biotech stock's past and future.
Via
The Motley Fool
Topics
Initial Public Offering
Intellectual Property
3 of Wall Street’s Favorite Stocks We Think Twice About
January 26, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...
Via
StockStory
Performance
YTD
-5.0%
-5.0%
1 Month
-3.6%
-3.6%
3 Month
+19.0%
+19.0%
6 Month
+41.0%
+41.0%
1 Year
+32.2%
+32.2%
More News
Read More
3 Small-Cap Stocks That Fall Short
January 12, 2026
Via
StockStory
Topics
Electric Vehicles
Reflecting On Pharmaceuticals Stocks’ Q3 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ)
December 28, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
3 Mid-Cap Stocks with Warning Signs
December 22, 2025
Via
StockStory
3 Reasons JAZZ is Risky and 1 Stock to Buy Instead
December 17, 2025
Via
StockStory
Topics
Bankruptcy
3 Value Stocks We’re Skeptical Of
December 11, 2025
Via
StockStory
This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy?
↗
December 09, 2025
Via
The Motley Fool
Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow?
↗
December 09, 2025
Via
The Motley Fool
Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets
↗
December 09, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
3 Healthcare Stocks We’re Skeptical Of
December 02, 2025
Via
StockStory
Topics
Stocks
Stocks making big moves yesterday: Dycom, ACV Auctions, Jazz Pharmaceuticals, Coinbase, and Gibraltar
November 18, 2025
Via
StockStory
3 of Wall Street’s Favorite Stocks Walking a Fine Line
November 17, 2025
Via
StockStory
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
↗
November 17, 2025
Via
Benzinga
Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans
↗
November 17, 2025
Via
Benzinga
Why Is Jazz Pharmaceuticals (JAZZ) Stock Soaring Today
November 17, 2025
Via
StockStory
Topics
Artificial Intelligence
Stocks
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday
↗
November 17, 2025
Via
Benzinga
The market is filled with gapping stocks in Monday's session.
↗
November 17, 2025
Via
Chartmill
Mixed Signals Point to Cautious Open for U.S. Markets as Tech Shines Amidst Economic Data Delays
November 17, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Electric Vehicles
Jazz, Zymeworks Catapult On Their 'Sweeping Success' In Gastric Cancer
↗
November 17, 2025
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 17, 2025
Via
Benzinga
The Top 5 Analyst Questions From Jazz Pharmaceuticals’s Q3 Earnings Call
November 12, 2025
Via
StockStory
Topics
Earnings
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
November 11, 2025
Via
StockStory
Topics
Artificial Intelligence
Stocks
JAZZ Q3 Deep Dive: New Drug Launches and Portfolio Expansion Drive Strong Results
November 06, 2025
Via
StockStory
Jazz Pharma (JAZZ) Earnings Call Transcript
↗
November 05, 2025
Via
The Motley Fool
Topics
Earnings
Frequently Asked Questions
Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 164.42
When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 01/28/26 11:54 AM ET
What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 10.25B
How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
Jazz Pharmaceuticals plc - Ordinary Shares has 10B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.